| [1] |
Siffel C, Kistler KD, Lewis JFM, et al. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review[J]. J Matern Fetal Neonatal Med, 2021, 34(11): 1721-1731. DOI: 10.1080/14767058.2019.1646240.
|
| [2] |
Gilfillan M, Bhandari A, Bhandari V. Diagnosis and management of bronchopulmonary dysplasia[J]. BMJ, 2021, 375: n1974. DOI: 10.1136/bmj.n1974.
|
| [3] |
Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia[J]. N Engl J Med, 1967, 276(7): 357-368. DOI: 10.1056/NEJM196702162760701.
|
| [4] |
|
| [5] |
Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary dysplasia: executive summary of a workshop[J]. J Pediatr, 197: 300-308. DOI: 10.1016/j.jpeds.2018.01.043.
|
| [6] |
Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach[J]. Am J Respir Crit Care Med, 2019, 200(6): 751-759. DOI: 10.1164/rccm.201812-2348OC.
|
| [7] |
Katz TA, Van-Kaam AH, Zuithoff NPA, et al. Association between bronchopulmonary dysplasia severity and its risk factors and long-term outcomes in three definitions: a historical cohort study[J]. Arch Dis Child Fetal Neonatal Ed, 2024, 110(1): 51-56. DOI: 10.1136/archdischild-2024-326931.
|
| [8] |
Ophelders DRMG, Gussenhoven R, Klein L, et al. Preterm brain injury, antenatal triggers, and therapeutics: timing is key[J]. Cells, 2020, 9(8): 1871. DOI: 10.3390/cells9081871.
|
| [9] |
Rantakari K, Rinta-Koski OP, Metsäranta M, et al. Early oxygen levels contribute to brain injury in extremely preterm infants[J]. Pediatr Res, 2021, 90(1): 131-139. DOI: 10.1038/s41390-021-01460-3.
|
| [10] |
Kim C, Ufkes S, Guo T, et al. Associations of bronchopulmonary dysplasia and infection with school-age brain development in children born preterm[J]. J Pediatr, 2025, 281: 114524. DOI: 10.1016/j.jpeds.2025.114524.
|
| [11] |
Dankhara N, Holla I, Ramarao S, et al. Bronchopulmonary dysplasia: pathogenesis and pathophysiology[J]. J Clin Med, 2023, 12(13): 4207. DOI: 10.3390/jcm12134207.
|
| [12] |
|
| [13] |
Pierrat V, Marchand-Martin L, Marret S, et al. Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study[J]. BMJ, 2021, 373: n741. DOI: 10.1136/bmj.n741.
|
| [14] |
Nguyen KL, Fitzgerald DA, Webb A, et al. Neurodevelopmental outcomes of extremely preterm infants with bronchopulmonary dysplasia (BPD): a retrospective cohort study[J]. Paediatr Respir Rev, 2024, 50: 23-30. DOI: 10.1016/j.prrv.2024.02.004.
|
| [15] |
Bell EF, Hintz SR, Hansen NI, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013-2018[J]. JAMA, 2022, 327(3): 248-263. DOI: 10.1001/jama.2021.23580.
|
| [16] |
Katz TA, van Kaam AH, Mugie SM, et al. Risk factors for neurodevelopmental impairment at 2- and 5-years corrected age in preterm infants with established bronchopulmonary dysplasia[J]. Neonatology, 2024, 121(1): 125-132. DOI: 10.1159/000533653.
|
| [17] |
Gotardo JW, Volkmer NFV, Stangler GP, et al. Impact of peri-intraventricular haemorrhage and periventricular leukomalacia in the neurodevelopment of preterms: a systematic review and Meta-analysis[J]. PLoS One, 2019, 14(10): e0223427. DOI: 10.1371/journal.pone.0223427.
|
| [18] |
Al-Matary A, Abozaid S, Al Suliman M, et al. Correlation between bronchopulmonary dysplasia and cerebral palsy in children: a comprehensive analysis using the national inpatient sample dataset[J]. Children (Basel), 2024, 11(9): 1129. DOI: 10.3390/children11091129.
|
| [19] |
Doyle LW, Mainzer R, Cheong JLY. Systemic postnatal corticosteroids, bronchopulmonary dysplasia, and survival free of cerebral palsy[J]. JAMA Pediatr, 2025, 179(1): 65-72. DOI: 10.1001/jamapediatrics.2024.4575.
|
| [20] |
Malavolti AM, Bassler D, Arlettaz-Mieth R, et al. Bronchopulmonary dysplasia-impact of severity and timing of diagnosis on neurodevelopment of preterm infants: a retrospective cohort study[J]. BMJ Paediatr Open, 2018, 2(1): e000165. DOI: 10.1136/bmjpo-2017-000165.
|
| [21] |
Twilhaar ES, Wade RM, De-Kieviet JF, et al. Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a Meta-analysis and Meta-regression[J]. JAMA Pediatr, 2018, 172(4): 361-367. DOI: 10.1001/jamapediatrics.2017.5323.
|
| [22] |
Sériès T, Guillot M, Angoa G, et al. Does growth velocity affect associations between birth weight and neurodevelopment for infants born very preterm[J]. J Pediatr, 2023, 260: 113531. DOI: 10.1016/j.jpeds.2023.113531.
|
| [23] |
Yazici A, Buyuktiryaki M, Simsek GK, et al. Factors associated with neurodevelopmental impairment in preterm infants with bronchopulmonary dysplasia[J]. Eur Rev Med Pharmacol Sci, 2022, 26(5): 1579-1585. DOI: 10.26355/eurrev_202203_28224.
|
| [24] |
Miller AN, Shepherd EG, El-Ferzli G, et al. Multidisciplinary bronchopulmonary dysplasia care[J]. Exp Rev Respir Med, 2023, 17(11): 989-1002. DOI: 10.1080/17476348.2023.2283120.
|
| [25] |
Shepherd EG, Knupp AM, Welty SE, et al. An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations[J]. J Perinatol, 2012, 32(1): 33-38. DOI: 10.1038/jp.2011.45.
|
| [26] |
Orton J, Doyle LW, Tripathi T, et al. Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants[J]. Cochrane Database Syst Rev, 2024, 2(2): CD005495. DOI: 10.1002/14651858.CD005495.pub5.
|
| [27] |
Oliphant EA, Hanning SM, McKinlay CJD, et al. Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and Meta-analysis[J]. J Perinatol, 2024, 44(6): 785-801. DOI: 10.1038/s41372-024-01939-x.
|
| [28] |
Mürner-Lavanchy IM, Doyle LW, Schmidt B, et al. Neurobehavioral outcomes 11 years after neonatal caffeine therapy for apnea of prematurity[J]. Pediatrics, 2018, 141(5): e20174047. DOI: 10.1542/peds.2017-4047.
|
| [29] |
Raghuveer TS, Zackula RE, Lakhotia R, et al. Systemic steroids and bronchopulmonary dysplasia: a systematic review and Meta-analysis[J]. J Perinatol, 2026， 46(2)：144-154. DOI: 10.1038/s41372-024-02097-w.
|
| [30] |
Watterberg KL, Walsh MC, Li L, et al. Hydrocortisone to improve survival without bronchopulmonary dysplasia[J]. N Engl J Med, 2022, 386(12): 1121-1131. DOI: 10.1056/NEJMoa2114897.
|